Dispenser for dispensing a fluid into a nasal cavity
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
Claims
The ornamental design for a dispenser for dispensing a fluid into a nasal cavity, as shown and described.
Referenced Cited
Patent History
Patent number: D546939
Type: Grant
Filed: Nov 6, 2006
Date of Patent: Jul 17, 2007
Assignee: Glaxo Group Limited (Greenford)
Inventors: Matthew Spencer Collins (Henlow), Hugh Alexander Connell (Evesham), Michael Birsha Davies (Ware), Andrew Robert Gibbs (Leamington Spa), Paul Kenneth Rand (Ware), Robert William Tansley (Bidford on Avon)
Primary Examiner: Ian Simmons
Assistant Examiner: W. Laymon
Attorney: James P. Riek
Application Number: 29/250,177
Type: Grant
Filed: Nov 6, 2006
Date of Patent: Jul 17, 2007
Assignee: Glaxo Group Limited (Greenford)
Inventors: Matthew Spencer Collins (Henlow), Hugh Alexander Connell (Evesham), Michael Birsha Davies (Ware), Andrew Robert Gibbs (Leamington Spa), Paul Kenneth Rand (Ware), Robert William Tansley (Bidford on Avon)
Primary Examiner: Ian Simmons
Assistant Examiner: W. Laymon
Attorney: James P. Riek
Application Number: 29/250,177
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110);
D9/724;
Resilient (e.g., Squeeze Bulb, Bellows, Etc.) (9) (D24/115)